Results 41 to 50 of about 1,374,790 (199)

Genome-wide study of resistant hypertension identified from electronic health records.

open access: yesPLoS ONE, 2017
Resistant hypertension is defined as high blood pressure that remains above treatment goals in spite of the concurrent use of three antihypertensive agents from different classes.
Logan Dumitrescu   +34 more
doaj   +1 more source

Resistant Hypertension: A Clinical Case

open access: yesRevista Ciencias de la Salud, 2018
Introduction: Secondary hypertension corresponds to 15 % of the causes of arterial hypertension, and among them, primary hyperaldosteronism presents a variable incidence of about 3% in hypertensive patients.
Joana Cascais Costa   +3 more
doaj   +1 more source

Decoding resistant hypertension signalling pathways [PDF]

open access: yes, 2017
Resistant hypertension (RH) is a clinical condition in which the hypertensive patient has become resistant to drug therapy and is often associated with increased cardiovascular morbidity and mortality.
Lima, Swiany Silveira   +16 more
core   +1 more source

Adipokines: Novel Players In Resistant Hypertension

open access: yes, 2015
Resistant hypertension (RH) is a multifactorial disease, frequently associated with obesity and characterized by blood pressure above goal (140/90 mm Hg) despite the concurrent use of ≥3 antihypertensive drugs of different classes.
de Faria A.P.   +3 more
core   +2 more sources

Mechanisms and treatment of resistant hypertension

open access: yes, 2008
Resistant hypertension is defined as blood pressure (BP) that remains uncontrolled in spite of the use of ≥3 antihypertensive medications. Stricter BP goals, higher obesity rates, older age, and increased use of exogenous BP-elevating substances are ...
Oparil, Suzanne   +5 more
core   +1 more source

Prevalence, Risk Factors and Cardiovascular Comorbidities of Resistant Hypertension among Treated Hypertensives in a Nigerian Population

open access: yesGlobal Heart
The true prevalence and cardiovascular comorbidities of resistant hypertension in Nigeria and Africa are not known. We sought to determine the prevalence and cardiovascular comorbidities of resistant hypertension in a treated Nigerian hypertensive ...
Olugbenga Olusola Abiodun   +3 more
doaj   +1 more source

Novel role of spironolactone in the therapy of resistant hypertension: Spironolactone and resistant hypertension [PDF]

open access: yesSerbian Journal of Anesthesia and Intensive Therapy, 2019
Spironolactone is a competitive nonselective mineralocorticoid receptor blocker with high affinity for aldosterone; therefore, it is widely used as a diuretic and antihypertensive.
Dragojević-Simić Viktorija   +4 more
doaj  

Resistant Hypertension or Resistant Prescribing? [PDF]

open access: yesHypertension, 2011
See related article, pp 1008–1013 The term “resistant hypertension” (RH) evokes a myriad of clinical descriptions, nearly all of which implicitly ascribe origins of the problem to characteristics inherent within the patient or maleficent qualities of the disease itself.
openaire   +2 more sources

Resistant Hypertension Revisited: Definition And True Prevalence

open access: yes, 2015
[No abstract available]3271546Smith, S.M., Gong, Y., Handberg, E., Messerli, F.H., Bakris, G.L., Ahmed, A., Predictors and outcomes of resistant hypertension among patients with coronary artery disease and hypertension (2014) J Hypertens, 32, pp.
De Faria A.P.   +3 more
core   +1 more source

Neuroadrenergic disarray in pseudo-resistant and resistant hypertension

open access: yes, 2014
Several studies have investigated the behavior of sympathetic cardiovascular drive in essential hypertension, providing conclusive evidence of the adrenergic activation characterizing this condition.
Grassi, Guido   +9 more
core   +1 more source

Home - About - Disclaimer - Privacy